General Hospital Of Athens Korgialenio Benakio H.R.C.

The 1st Cardiology Clinic at General Hospital Of Athens Korgialenio Benakio H.R.C. focuses on preventing clot‑related events such as ischemic stroke. It also evaluates new anticoagulant strategies for patients with atrial fibrillation.

• Oral FXIa inhibitor asundexian for secondary stroke prevention
• Comparison of asundexian with apixaban in atrial fibrillation
• Assessment of major bleeding risk with novel anticoagulants

These studies aim to improve outcomes for high‑risk cardiovascular patients while carefully monitoring safety.

The clinic conducts research on severe infections, employing biomarker‑guided approaches to reduce use of broad-spectrum antibiotics. One focus is the integration of procalcitonin testing to tailor therapy duration.

• Procalcitonin‑guided antibiotic stewardship
• Molecular diagnostics for rapid pathogen identification
• Reduction of treatment duration in severe infections

The objective is to optimize antimicrobial use, limit resistance, and ensure effective patient care.